182 related articles for article (PubMed ID: 28602553)
1. Proteomic profiling of the brain of mice with experimental cerebral malaria.
Moussa E; Huang H; Ahras M; Lall A; Thezenas ML; Fischer R; Kessler BM; Pain A; Billker O; Casals-Pascual C
J Proteomics; 2018 May; 180():61-69. PubMed ID: 28602553
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
4. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of
Yi H; Jiang W; Yang F; Li F; Li Y; Zhu W; Li Q; Fakhar SH; Cao Y; Luo L; Zhang W; He Y
Front Immunol; 2021; 12():719189. PubMed ID: 34456927
[TBL] [Abstract][Full Text] [Related]
5. Cerebral Malaria Is Regulated by Host-Mediated Changes in
Cimperman CK; Pena M; Gokcek SM; Theall BP; Patel MV; Sharma A; Qi C; Sturdevant D; Miller LH; Collins PL; Pierce SK; Akkaya M
mBio; 2023 Apr; 14(2):e0339122. PubMed ID: 36852995
[TBL] [Abstract][Full Text] [Related]
6. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
7. Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content.
Tiberti N; Latham SL; Bush S; Cohen A; Opoka RO; John CC; Juillard A; Grau GE; Combes V
Sci Rep; 2016 Dec; 6():37871. PubMed ID: 27917875
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
10. Blood-cerebrospinal fluid barrier: another site disrupted during experimental cerebral malaria caused by Plasmodium berghei ANKA.
Ngo-Thanh H; Sasaki T; Suzue K; Yokoo H; Isoda K; Kamitani W; Shimokawa C; Hisaeda H; Imai T
Int J Parasitol; 2020 Dec; 50(14):1167-1175. PubMed ID: 32882285
[TBL] [Abstract][Full Text] [Related]
11. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.
O'Regan N; Gegenbauer K; O'Sullivan JM; Maleki S; Brophy TM; Dalton N; Chion A; Fallon PG; Grau GE; Budde U; Smith OP; Craig AG; Preston RJ; O'Donnell JS
Blood; 2016 Mar; 127(9):1192-201. PubMed ID: 26511133
[TBL] [Abstract][Full Text] [Related]
12. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
13. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
14. Fenozyme Protects the Integrity of the Blood-Brain Barrier against Experimental Cerebral Malaria.
Zhao S; Duan H; Yang Y; Yan X; Fan K
Nano Lett; 2019 Dec; 19(12):8887-8895. PubMed ID: 31671939
[TBL] [Abstract][Full Text] [Related]
15. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
Keita Alassane S; Nicolau-Travers ML; Menard S; Andreoletti O; Cambus JP; Gaudre N; Wlodarczyk M; Blanchard N; Berry A; Abbes S; Colongo D; Faye B; Augereau JM; Lacroux C; Iriart X; Benoit-Vical F
PLoS One; 2017; 12(7):e0181300. PubMed ID: 28742109
[TBL] [Abstract][Full Text] [Related]
16. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of the plasma of Gambian children with cerebral malaria.
Moussa EM; Huang H; Thézénas ML; Fischer R; Ramaprasad A; Sisay-Joof F; Jallow M; Pain A; Kwiatkowski D; Kessler BM; Casals-Pascual C
Malar J; 2018 Sep; 17(1):337. PubMed ID: 30249265
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.
Freeman BD; Martins YC; Akide-Ndunge OB; Bruno FP; Wang H; Tanowitz HB; Spray DC; Desruisseaux MS
PLoS Pathog; 2016 Mar; 12(3):e1005477. PubMed ID: 27031954
[TBL] [Abstract][Full Text] [Related]
19. Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria.
Cohen A; Zinger A; Tiberti N; Grau GER; Combes V
Malar J; 2018 May; 17(1):192. PubMed ID: 29747626
[TBL] [Abstract][Full Text] [Related]
20. Experimental cerebral malaria is associated with profound loss of both glycan and protein components of the endothelial glycocalyx.
Hempel C; Sporring J; Kurtzhals JAL
FASEB J; 2019 Feb; 33(2):2058-2071. PubMed ID: 30226810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
